tiprankstipranks
Trending News
More News >
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
US Market
Advertisement

Galmed Pharmaceuticals (GLMD) Financial Statements

Compare
1,304 Followers

Galmed Pharmaceuticals Financial Overview

Galmed Pharmaceuticals's market cap is currently $7.67M. The company's EPS TTM is $-0.63; its P/E ratio is ―; Galmed Pharmaceuticals is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Galmed Pharmaceuticals Earnings and Revenue History

Galmed Pharmaceuticals Debt to Assets

Galmed Pharmaceuticals Cash Flow

Galmed Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis